|
Volumn 24, Issue 7, 1997, Pages 829-836
|
Evaluation of urinary NMP22 (Nuclear Matrix Protein 22) as a diagnostic marker for urothelial cancer - NMP22 as a urinary marker for surveillance of bladder cancer
a a a a a a a a a a a a a a a |
Author keywords
Bladder neoplasms; NMP22; Urinary marker; Voided urine cytology
|
Indexed keywords
NUCLEAR PROTEIN;
TUMOR MARKER;
ARTICLE;
BLADDER CANCER;
CANCER DIAGNOSIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC ACCURACY;
HUMAN;
HUMAN CELL;
INTERMETHOD COMPARISON;
KIDNEY CANCER;
MAJOR CLINICAL STUDY;
PROSTATE CANCER;
TUMOR VOLUME;
URINARY EXCRETION;
URINE CYTOLOGY;
ADULT;
AGED;
CARCINOMA, TRANSITIONAL CELL;
FEMALE;
HUMANS;
KIDNEY NEOPLASMS;
MALE;
MIDDLE AGED;
MULTIVARIATE ANALYSIS;
NUCLEAR PROTEINS;
PROSTATIC NEOPLASMS;
TUMOR MARKERS, BIOLOGICAL;
URINARY BLADDER NEOPLASMS;
|
EID: 0030885042
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (13)
|